Skip to main content

Peer Review reports

From: Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV

Original Submission
2 Feb 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
31 Mar 2021 Reviewed Reviewer Report
1 Jun 2021 Reviewed Reviewer Report
15 Jun 2021 Author responded Author comments - Gilles Darcis
Resubmission - Version 4
15 Jun 2021 Submitted Manuscript version 4
1 Jul 2021 Author responded Author comments - Gilles Darcis
Resubmission - Version 5
1 Jul 2021 Submitted Manuscript version 5
Publishing
19 Jul 2021 Editorially accepted
6 Sep 2021 Article published 10.1186/s12879-021-06479-9

You can find further information about peer review here.

Back to article page